SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950134-05-013572
Filing Date
2005-07-19
Accepted
2005-07-19 15:10:55
Documents
7
Period of Report
2005-07-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f10782e8vk.htm 8-K 22632
2 EXHIBIT 4.1 f10782exv4w1.htm EX-4.1 260222
3 EXHIBIT 4.2 f10782exv4w2.htm EX-4.2 196198
4 EXHIBIT 4.6 f10782exv4w6.htm EX-4.6 101794
5 EXHIBIT 99.1 f10782exv99w1.htm EX-99.1 5497
6 EXHIBIT 99.2 f10782exv99w2.htm EX-99.2 5710
7 GRAPHIC f10782f1078200.gif GRAPHIC 2536
  Complete submission text file 0000950134-05-013572.txt   597371
Mailing Address 1 DNA WAY . SOUTH SAN FRANCISCO CA 94080
Business Address 1 DNA WAY SOUTH SAN FRANCISCO CA 94080 650-225-1000
GENENTECH INC (Filer) CIK: 0000318771 (see all company filings)

IRS No.: 942347624 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-09813 | Film No.: 05961508
SIC: 2834 Pharmaceutical Preparations